tiprankstipranks
Trending News
More News >

Jim Wassil Insider Profile

4 Followers
Jim Wassil, COO at Vaxcyte, holds 146.27K shares in Vaxcyte (Ticker: PCVX), holds 0.00 shares in Icosavax (Ticker: ICVX).
tipranks
Jim Wassil

Jim Wassil
Vaxcyte (PCVX)
COO

Not Ranked
Jim Wassil has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$5M
100.00%
A breakdown of Jim Wassil's holdings

Insider Roles

Vaxcyte
(PCVX)
COO
Roles that Jim Wassil holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Jim Wassil

Jim Wassil's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Vaxcyte
Sep 04, 2025
COO
Uninformative Sell
40.08K
$4.83M
ICVX
Icosavax
Feb 20, 2024
Uninformative Sell
$0.00
List of latest transactions for each holding click on a transaction to see Jim Wassil's performance on stock

Jim Wassil insider profile FAQ

What is the percentage of profitable transactions made by Jim Wassil?
The percentage of profitable transactions made by Jim Wassil is ―.
    What is the average return per transaction made by Jim Wassil?
    The average return per transaction made by Jim Wassil is ―.
      What stocks does Jim Wassil hold?
      Jim Wassil holds: PCVX, ICVX stocks.
        What was Jim Wassil’s latest transaction?
        Jim Wassil latest transaction was an Uninformative Sell of $40.08K.
          What was Jim Wassil's most profitable transaction?
          Jim Wassil’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Jim Wassil's role in Vaxcyte?
            Jim Wassil's role in Vaxcyte is COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.